Compare TGE & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGE | SINT |
|---|---|---|
| Founded | 2023 | 1996 |
| Country | France | United States |
| Employees | 166 | N/A |
| Industry | Newspapers/Magazines | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 11.7M |
| IPO Year | N/A | 2007 |
| Metric | TGE | SINT |
|---|---|---|
| Price | $0.19 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | ★ 880.8K | 26.6K |
| Earning Date | 09-30-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,018,000.00 |
| Revenue This Year | N/A | $230.23 |
| Revenue Next Year | N/A | $112.70 |
| P/E Ratio | $2.99 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.18 | $1.18 |
| 52 Week High | $1.69 | $4.46 |
| Indicator | TGE | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 24.12 | 22.02 |
| Support Level | N/A | N/A |
| Resistance Level | $0.99 | $1.86 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 8.06 | 8.95 |
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications.